Financials in USD. Standardized financial statements.
A compact view of how Sundrug Co.,Ltd. turns revenue into operating income and net income.
| Metric | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $847.82B | $801.81B | $751.78B | $690.46B | $648.73B | $634.31B | $5.72B | $5.31B | $5.31B | $4.74B |
| Revenue Growth? | +5.7% | +6.7% | +8.9% | +6.4% | +2.3% | +10984.6% | +7.7% | +0.1% | +11.9% | 0.0% |
| Cost of Revenue? | $649.16B | $597.72B | $562.46B | $3.90B | $4.04B | $4.31B | $4.29B | $3.98B | $3.98B | $3.57B |
| Gross Profit? | $198.65B | $204.09B | $189.32B | $1.29B | $1.29B | $1.43B | $1.43B | $1.33B | $1.33B | $1.17B |
| Gross Margin? | +23.4% | +25.5% | +25.2% | +0.2% | +0.2% | +0.2% | +25.0% | +25.0% | +25.0% | +24.7% |
| Operating Expenses? | $151.53B | $159.59B | $148.32B | $1.01B | $1.01B | $121.20B | $1.09B | $1.01B | $986.16M | $867.74M |
| Operating Income? | $47.13B | $44.50B | $41.00B | $37.45B | $34.05B | $37.34B | $339.09M | $318.33M | $339.27M | $305.63M |
| EBITDA? | $66.01B | $61.02B | $56.12B | $49.81B | $44.89B | $45.86B | $43.02B | $43.32B | $44.39B | $41.40B |
| Income Before Tax | $46.09B | $43.57B | $41.26B | $37.71B | $34.67B | $37.19B | $320.95M | $316.85M | $344.13M | $308.93M |
| Income Tax Expense | $14.50B | $12.82B | $12.13B | $12.01B | $10.82B | $11.86B | $101.49M | $100.62M | $110.65M | $99.72M |
| Net Income? | $31.59B | $30.75B | $29.13B | $25.70B | $23.85B | $25.33B | $219.46M | $216.23M | $233.46M | $209.21M |
| EPS? | $270.03 | $262.91 | $249.07 | $219.83 | $204.02 | $216.68 | $1.88 | $1.85 | $2.00 | $1.77 |
| Diluted EPS? | $270.03 | $262.91 | $249.07 | $219.82 | $204.01 | $216.63 | $1.88 | $1.85 | $2.00 | $1.77 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality